RESEARCH PROJECTS SUPPORTED BY THE NATIONAL LEIOMYOSARCOMA FOUNDATION THROUGH YOUR GRACIOUS “GIFT” WILL “ KEEP ON GIVING” TO PATIENTS ALL OVER THE COUNTRY / ALL OVER THE WORLD!
“We won’t know whose lives we have touched and made better for having cared . . .
What’s important is that we DO CARE…. and ACT!”
THE AMAZING IMPACT YOUR “INVESTMENT” IN RARE CANCER RESEARCH WILL MAKE . . .
- The p53 Project- the study of Elephants who do not get cancer! Currently this research work is being done by several labs throughout the country, but the Foundation is supportingDr. Josh Schiffman of the Huntsman Cancer Institute in Salt Lake City, UT because he is focusingon Leiomyosarcoma (LMS).
- The SPORE Project – involving the study of new biologically-rational trials to evaluate patient response to a multidisciplinary approach to treatment therapies – combinations of therapies.
Such research exploration has potential to accelerate treatment advancement for a full spectrum of sarcoma landscapes – different sarcomas including Leiomyosarcoma.
- The DNA Project – involving the study of circulating DNA for Leiomyosarcoma patients. From this study clinicians could identify patients who could safely undergo laparoscopic procedures to remove tumors. A liquid biopsy test based on the analysis of tumor associated genetics can help guide clinicians in such procedures in the near future, and even assess the microtumor environment within the body.
- THE CANCER CELL LINE PROJECT – Tumor tissue voluntarily donated by a patient prior to surgery will be de-identified for processing and cultivation by the Broad Institute of MIT/Harvard – to grow cell lines to increase research capabilities on a global scale, by amplifying data generation and tumor material to enhance global research initiatives.
The one thing we have all probably read about and learned is: Research breakthroughs have and will continue to have significant treatment potential for a variety of cancer types. Therefore, when research breakthroughs occur – there is hope on the horizon for many cancer patients be the beneficiaries and impact their survival.